Review



tris based antigen retrieval buffer  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Vector Laboratories tris based antigen retrieval buffer
    Tris Based Antigen Retrieval Buffer, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 3158 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tris+based+antigen+retrieval+buffer/Antigen+Unmasking+Solution%2C+Tris-Based/pmc13058276-559-16-20
    Average 96 stars, based on 3158 article reviews
    tris based antigen retrieval buffer - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Immunofluorescence:

    Article Title: DCPS modulates TDP-43 mediated neurodegeneration through P-body regulation
    Article Snippet: .. For immunofluorescence of mouse spinal cords, floating sections were transferred to PBS, followed by boiling in Tris-based antigen retrieval buffer (Vector Laboratories, H-3301-250) at 95°C for 20 min. ..

    Article Title: DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay
    Article Snippet: .. For immunofluorescence of mouse spinal cords, floating sections were transferred to PBS, followed by boiling in Tris-based antigen retrieval buffer (Vector Laboratories, Cat. No. H-3301-250) at 95 ◦ C for 20 min. ..

    Article Title: DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay
    Article Snippet: .. For immunofluorescence of mouse spinal cords, floating sections were transferred to PBS, followed by boiling in Tris-based antigen retrieval buffer (Vector Laboratories, Cat. No. H-3301–250) at 95 ◦ C for 20 min. ..

    other:

    Article Title: DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay
    Article Snippet: Tris-based antigen retrieval buffer , Vector Laboratories , Cat #H-3301–250.



    Similar Products

    tris based antigen retrieval buffer  (Vector Laboratories)
    96
    Vector Laboratories tris based antigen retrieval buffer
    Tris Based Antigen Retrieval Buffer, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tris+based+antigen+retrieval+buffer/Antigen+Unmasking+Solution%2C+Tris-Based/pmc13058276-559-16-20
    Average 96 stars, based on 1 article reviews
    tris based antigen retrieval buffer - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    antigen retrieval buffer  (Vector Laboratories)
    96
    Vector Laboratories antigen retrieval buffer
    Antigen Retrieval Buffer, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tris+based+antigen+retrieval+buffer/Antigen+Unmasking+Solution%2C+Tris-Based/pmc13032258-138-15-18
    Average 96 stars, based on 1 article reviews
    antigen retrieval buffer - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    antigen retrieval buffer a endogenous peroxidases  (Vector Laboratories)
    96
    Vector Laboratories antigen retrieval buffer a endogenous peroxidases
    a , b Au565 cells were assessed for T-DXd ( a ) or T-DM1 ( b ) cytotoxicity in vitro in the presence of CTSL inhibitor (3 µM Z-Phe-Phe-FMK). c Au565 cells overexpressing CTSL or lacking CTSL were assessed for T-DXd cytotoxicity in vitro. d Extracellular CTSL secretion by MDA-MB-231 lines was quantified with ELISA analysis of conditioned media. e Secreted proteins in conditioned media of indicated cell lines were concentrated and quantified for CTSL enzymatic activity in assay buffer. a – e Two-way ANOVA with Tukey’s multiple comparisons test ( n = 3 per group). Nonlinear regression curve fit to calculate IC50 values. f Parental and CTSL-overexpressed MDA-MB-231 cells were implanted in SCID mice, and treated with T-DXd (5 mg/kg) or control PBS. g Control-KO and CTSL-KO MDA-MB-231 cells were implanted in SCID mice, and treated with T-DXd (10 mg/kg) or control PBS. f – h Mixed-effects analysis (REML) with Tukey’s multiple comparisons ( n = 10). Arrows indicate time of treatments administered. h Tumor sizes (mm 3 ) measured at end point for studies using MDA-MB-231 CTSL-KO lines. i Immunohistochemistry verifications of CTSL expression in parental or CTSL-modified MDA-MB-231 tumors. j LC-MS quantification of DXd in MDA-MB-231 parental ( n = 15) versus CTSL-overexpressed tumors ( n = 10), treated with T-DXd (10 mg/kg) for 5 days. k LC-MS quantification of DXd in MDA-MB-231 control-KO versus three different CTSL-KO pools, treated with T-DXd (10 mg/kg) for 3 days ( n = 10 for all groups, except n = 6 for CTSL-KO #2). h , k One-way ANOVA with Tukey’s multiple comparisons. j Two-sided Mann–Whitney test. All data is presented as mean ± SEM with p values indicated.
    Antigen Retrieval Buffer A Endogenous Peroxidases, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tris+based+antigen+retrieval+buffer/Antigen+Unmasking+Solution%2C+Tris-Based/pmc11965298-505-5-17
    Average 96 stars, based on 1 article reviews
    antigen retrieval buffer a endogenous peroxidases - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    a , b Au565 cells were assessed for T-DXd ( a ) or T-DM1 ( b ) cytotoxicity in vitro in the presence of CTSL inhibitor (3 µM Z-Phe-Phe-FMK). c Au565 cells overexpressing CTSL or lacking CTSL were assessed for T-DXd cytotoxicity in vitro. d Extracellular CTSL secretion by MDA-MB-231 lines was quantified with ELISA analysis of conditioned media. e Secreted proteins in conditioned media of indicated cell lines were concentrated and quantified for CTSL enzymatic activity in assay buffer. a – e Two-way ANOVA with Tukey’s multiple comparisons test ( n = 3 per group). Nonlinear regression curve fit to calculate IC50 values. f Parental and CTSL-overexpressed MDA-MB-231 cells were implanted in SCID mice, and treated with T-DXd (5 mg/kg) or control PBS. g Control-KO and CTSL-KO MDA-MB-231 cells were implanted in SCID mice, and treated with T-DXd (10 mg/kg) or control PBS. f – h Mixed-effects analysis (REML) with Tukey’s multiple comparisons ( n = 10). Arrows indicate time of treatments administered. h Tumor sizes (mm 3 ) measured at end point for studies using MDA-MB-231 CTSL-KO lines. i Immunohistochemistry verifications of CTSL expression in parental or CTSL-modified MDA-MB-231 tumors. j LC-MS quantification of DXd in MDA-MB-231 parental ( n = 15) versus CTSL-overexpressed tumors ( n = 10), treated with T-DXd (10 mg/kg) for 5 days. k LC-MS quantification of DXd in MDA-MB-231 control-KO versus three different CTSL-KO pools, treated with T-DXd (10 mg/kg) for 3 days ( n = 10 for all groups, except n = 6 for CTSL-KO #2). h , k One-way ANOVA with Tukey’s multiple comparisons. j Two-sided Mann–Whitney test. All data is presented as mean ± SEM with p values indicated.

    Journal: Nature Communications

    Article Title: Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)

    doi: 10.1038/s41467-025-58266-8

    Figure Lengend Snippet: a , b Au565 cells were assessed for T-DXd ( a ) or T-DM1 ( b ) cytotoxicity in vitro in the presence of CTSL inhibitor (3 µM Z-Phe-Phe-FMK). c Au565 cells overexpressing CTSL or lacking CTSL were assessed for T-DXd cytotoxicity in vitro. d Extracellular CTSL secretion by MDA-MB-231 lines was quantified with ELISA analysis of conditioned media. e Secreted proteins in conditioned media of indicated cell lines were concentrated and quantified for CTSL enzymatic activity in assay buffer. a – e Two-way ANOVA with Tukey’s multiple comparisons test ( n = 3 per group). Nonlinear regression curve fit to calculate IC50 values. f Parental and CTSL-overexpressed MDA-MB-231 cells were implanted in SCID mice, and treated with T-DXd (5 mg/kg) or control PBS. g Control-KO and CTSL-KO MDA-MB-231 cells were implanted in SCID mice, and treated with T-DXd (10 mg/kg) or control PBS. f – h Mixed-effects analysis (REML) with Tukey’s multiple comparisons ( n = 10). Arrows indicate time of treatments administered. h Tumor sizes (mm 3 ) measured at end point for studies using MDA-MB-231 CTSL-KO lines. i Immunohistochemistry verifications of CTSL expression in parental or CTSL-modified MDA-MB-231 tumors. j LC-MS quantification of DXd in MDA-MB-231 parental ( n = 15) versus CTSL-overexpressed tumors ( n = 10), treated with T-DXd (10 mg/kg) for 5 days. k LC-MS quantification of DXd in MDA-MB-231 control-KO versus three different CTSL-KO pools, treated with T-DXd (10 mg/kg) for 3 days ( n = 10 for all groups, except n = 6 for CTSL-KO #2). h , k One-way ANOVA with Tukey’s multiple comparisons. j Two-sided Mann–Whitney test. All data is presented as mean ± SEM with p values indicated.

    Article Snippet: Antigen unmasking was performed with antigen retrieval buffer A. Endogenous peroxidases/phosphatases were quenched with BLOXALL blocking solution (Vector), and tissues were blocked with Animal-Free Blocker R.T.U. (Vector).

    Techniques: In Vitro, Enzyme-linked Immunosorbent Assay, Activity Assay, Control, Immunohistochemistry, Expressing, Modification, Liquid Chromatography with Mass Spectroscopy, MANN-WHITNEY